| 3.1 Death before discharge |
3 |
224 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.21, 4.82] |
| 3.2 Days to regain birth weight |
3 |
223 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.19 [‐2.00, 1.62] |
| 3.3 Rate of weight gain (g/kg/day) |
2 |
123 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.42 [‐5.15, 4.30] |
| 3.4 Bronchopulmonary dysplasia/chronic lung disease |
4 |
261 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.69 [0.46, 1.04] |
| 3.5 Bronchopulmonary dysplasia/chronic lung disease (sensitivity analysis) |
3 |
197 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.01 [0.57, 1.79] |
| 3.6 Duration of ventilation (days) |
3 |
202 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.20 [‐1.67, 1.26] |
| 3.7 Duration of supplemental oxygen (days) |
2 |
102 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.76 [‐16.99, 15.47] |
| 3.8 Need for home oxygen therapy |
1 |
64 |
Risk Difference (M‐H, Fixed, 95% CI) |
0.00 [‐0.06, 0.06] |
| 3.9 Culture positive sepsis |
2 |
164 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.22 [0.54, 2.78] |
| 3.10 Any sepsis (clinical and/or culture positive) |
5 |
301 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.87 [0.56, 1.36] |
| 3.11 Necrotising enterocolitis (≥ stage 2) |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.10 [0.13, 73.14] |
| 3.12 Significant jaundice requiring treatment |
2 |
109 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.04 [0.52, 2.07] |
| 3.13 Duration of phototherapy (days) |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.10 [‐1.08, 0.88] |
| 3.14 Intraventricular haemorrhage (grade III‐IV) |
2 |
104 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.50 [0.10, 2.61] |
| 3.15 Periventricular leukomalacia |
1 |
64 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.01, 7.89] |
| 3.16 Any patent ductus arteriosus |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.03 [0.63, 1.71] |
| 3.17 Air leaks |
1 |
64 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.50 [0.05, 5.24] |
| 3.18 Parenteral nutrition associated liver disease/cholestasis |
4 |
261 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.26, 3.86] |
| 3.19 Hypertriglyceridaemia |
2 |
104 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.67 [0.12, 3.73] |
| 3.20 Hyperglycaemia |
1 |
64 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.22, 4.59] |
